Timo Rath

Prof. Dr. Timo Rath

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2019 in World Journal of Gastroenterology
Verified
Journal Article
Open access
FVFrancesco Vitali
Francesco Vitali
ANAndreas Naegel
Andreas Naegel
RARaja Atreya
Raja Atreya
SZSteffen Zopf
Steffen Zopf
CNClemens Neufert
Clemens Neufert
TRTimo Rath
Timo Rath
Comparison of Hemospray® and Endoclot™ for the treatment of gastrointestinal bleeding

12 January 2018 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
FVFrancesco Vitali
Francesco Vitali
ANAndreas Naegel
Andreas Naegel
JSJuergen Siebler
Juergen Siebler
MNMarkus F. Neurath
Markus F. Neurath
TRTimo Rath
Timo Rath
Background and study aims The full-thickness resection device (FTRD) represents a novel endoscopic treatment method for lesions unresectable with conventional endoscopic techniques. The overall aim of this study was to evaluate technical success and in toto resection rates, recurrence rates, as well as immediate or late complications in patients who underwent polyp removal with the FTRD. Patients and methods Data from a prospectively collected database of 12 patients who underwent 13 over-the-scope clip-based full-thickness resections between June 2015 and June 2017 were analyzed. Follow-up endoscopy was performed in 11 out of 12 patients. Results 13 full-thickness resections were performed in 7 males and 5 females (mean age 64.3 ± 6.3 years). Mean size of the lesions removed with FTRD was 17 ± 4 mm. Location was rectum (n = 6), cecum (n = 2), ascending colon (n = 2), left flexure (n = 1) and right flexure (n = 2). Mean procedure time was 68 ± 35 minutes and mean hospital stay was 2.5 ± 1.2 days. 2 patients developed post-polypectomy syndrome, which resolved after conservative treatment. No perforations and no immediate surgical revision were needed. Histology of the 13 lesions removed with FTRD showed 5 adenomas with low grade intraepithelial neoplasia (IEN), 4 high grade IEN, 1 fibrosis, 1 fibrosis without dysplasia and 2 adenocarcinomas. Technical success was achieved in all procedures (13/13, 100 %). R0 resection was achieved in 10/12 patients (83.3 %). 2 patients underwent surgery because of recurrence or not evaluable margins. In 1 patient no residual malignancy was proven in histological examination, in the other patient residual low grade IEN adenoma. Conclusion FTRD is a minimally invasive approach with good success rate of complete resection and minimal side effects.

30 January 2015 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
TRTimo Rath
Timo Rath
UBUlrike Billmeier
Ulrike Billmeier
MWMaximilian J. Waldner
Maximilian J. Waldner
RARaja Atreya
Raja Atreya
MNMarkus F Neurath
Markus F Neurath

17 June 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TRTimo Rath
Timo Rath
WDWalburga Dieterich
Walburga Dieterich
CKChristiane Kätscher-Murad
Christiane Kätscher-Murad
MNMarkus F. Neurath
Markus F. Neurath
YZYurdagül Zopf
Yurdagül Zopf
Food allergy (FA) affects approximately 3 to 4% of the adult population in westernized countries. Suspected FA is even more prevalent and requires extensive diagnostic work-up. Within this study, we evaluated whether assessment of the integrity of the epithelial barrier by confocal laser endomicroscopy (CLE) during colonoscopy can be used as a screening tool to identify patients with FA. 60 patients with suspected FA were prospectively included. Serology with total and food-specific IgE, anti-tissue transglutaminase, skin prick testing, food intolerance tests, food intake registration and assessment of clinical complaints were performed. During colonocopy, standardized CLE was performed in the terminal ileum and at two colorectal sites. Analysis of CLE images included functional (i.e. presence of epithelial barrier dysfunction) and quantitative parameters of intestinal architecture. 27 of 60 patients (45%) were diagnosed with FA. Barrier dysfunction was analyzed on 65.837 ileal and on 93.251 colonic images. 96% of patients with FA exhibited functional and structural barrier defects while barrier dysfunction was found in only 33% of patients without FA (p < 0.0001). Visualizing barrier dysfunction with CLE for in vivo diagnosis of FA had a sensitivity and specificity of 96% and 67%, respectively, with a positive and negative prediction of 70% and 96%, respectively. Parameters intrinsic to the crypt architecture including crypt diameter, intercrypt distance, crypt lumen diameter and colonic vasculature were not different between patients with and without FA. CLE-based imaging of the intestinal barrier during colonoscopy might help in stratifying patients with suspected FA for further diagnostic work-up.

12 September 2011 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
TRTimo Rath
Timo Rath
MRMartin Roderfeld
Martin Roderfeld
CGCan Güler
Can Güler
CWChristian Helmut Wenzel
Christian Helmut Wenzel
JGJürgen Graf
Jürgen Graf
RZReinhart Zachoval
Reinhart Zachoval
Objective. Transient elastography (TE) is a non-invasive and accurate method for the diagnosis of severe hepatic fibrosis and cirrhosis (F = 3 and F = 4). However, the assessment of significant fibrosis (F = 2) by TE is impaired due to a high variation in the diagnostic accuracy. Within this study, we aim to compare the diagnostic value of TE and experimental biomarkers of liver fibrosis. Material and methods. A total of 55 patients with chronic liver disease of different etiologies were included in the study. Among them, patients with HCV infection represented the largest cohort (n = 25). Liver fibrosis was evaluated according to the Desmet/Scheuer score. All patients received TE. Serum concentrations of YKL-40, hyaluronic acid (HA), Laminin, C-terminal procollagen I peptide, MMP-9, TIMP-1, TIMP-2 and MMP-9/TIMP-1 complex were determined by ELISA. Results. In the total patient population, areas under the receiver operator characteristic curve (AUROC) for TE were 0.798 (F ≥ 2), 0.880 (F ≥ 3) and 1 (F = 4). Among the serum markers, highest diagnostic accuracies were calculated for YKL-40 for F ≥ 2 (0.792) and F ≥ 3 (0.914) and for YKL-40 and HA for F = 4 (both 0.936). In the subgroup of HCV patients, the following AUROCs for TE were calculated: 0.802 (F ≥ 2), 0.798 (F ≥ 3) and 0.998 (F = 4). YKL-40 exhibited the highest diagnostic accuracy of all biomarkers in the HCV population (0.880, 0.854 and 0.986, respectively). Conclusions. YKL-40 is a powerful fibrosis marker with high diagnostic accuracy, in particular in HCV-associated liver disease. Its determination may confirm and improve the diagnostic accuracy of TE especially in early stages of liver fibrosis.

29 January 2021 in Expert Review of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
TRTimo Rath
Timo Rath
RARaja Atreya
Raja Atreya
MNMarkus F. Neurath
Markus F. Neurath
Currently, treatment goals in ulcerative colitis aim to achieve clinical remission and endoscopic mucosal healing. Emerging evidence suggests that histologic assessment of inflammation is a sensiti...